SALSA-SGC

Enabling all Australians with MND to contribute to a big-data research resource that integrates clinical, lifestyle and biological information.

1089

CASES

2298

CLINICAL VISITS

1705

SAMPLES

932

GENOTYPED

RESEARCH HIGHLIGHTS

FEATURED RESEARCH PROJECT

Using human serum and plasma to determine novel biomarkers for neurodegenerative diseases

Taking results from animal models, this project will screen blood lipids found to be markers of disease progression. Serum and plasma samples accessed from SALSA-SGC will be used for targeted screening of blood lipids knowing that lipid metabolism plays a crucial role in MND. This research will be conducted at the Florey Institute in Melbourne, Victoria, and results are expected late 2022.

Interested in finding out more about this study? Please contact Sophia Luikinga: s.luikinga@florey.edu.au

LATEST PUBLICATIONS

Subscribe to our mailing list to keep up to date with the latest SALSA-SGC news.

OUR PARTNERS AND SUPPORTERS